44
Views
6
CrossRef citations to date
0
Altmetric
Review

Design and analysis considerations for thorough QT studies employing conventional (10 s, 12-lead) ECG recordings

, &
Pages 815-839 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Rashmi R. Shah & Joel Morganroth. (2012) Early Investigation of QTc Liability. Drug Safety 35:9, pages 695-709.
Crossref
Rashmi R. Shah & Joel Morganroth. (2012) Early Investigation of QTc Liability. Drug Safety 35:9, pages 695-709.
Crossref
Arne Ring, Andreas Port, E. Ulrike Graefe-Mody, Ivette Revollo, Mario Iovino & Klaus A. Dugi. (2011) The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses. British Journal of Clinical Pharmacology 72:1, pages 39-50.
Crossref
Lawrence Z. Satin, Todd A. Durham & J. Rick Turner. (2011) Assessing a Drug’s Proarrhythmic Liability: An Overview of Computer Simulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study. Drug Information Journal 45:3, pages 357-375.
Crossref
J. Rick TurnerJ. Rick Turner. 2010. New Drug Development. New Drug Development 195 210 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.